These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2907343)

  • 1. Cell mediated immunity in sarcoidosis.
    Dutta SK; Gupta SK; Mitra K
    J Indian Med Assoc; 1988 Oct; 86(10):259-61. PubMed ID: 2907343
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunological competence of subjects with sarcoidosis.
    Mangi RJ; Dwyer JM; Gee B; Kantor FS
    Clin Exp Immunol; 1974 Dec; 18(4):505-17. PubMed ID: 4283120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of the intradermal reaction with lepromin in sarcoidosis patients].
    Proença NG; Zaitz C; Duarte I; Kliemann TA
    Med Cutan Ibero Lat Am; 1985; 13(6):471-4. PubMed ID: 3914598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunity in sarcoidosis].
    Ricci C; Minetto E; Cascio G; Anania A; Omedé P; Valente E
    Recenti Prog Med; 1979 Jul; 67(1):40-69. PubMed ID: 396616
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte subpopulations in sarcoidosis.
    Hedfors E; Holm G; Pettersson D
    Clin Exp Immunol; 1974 Jun; 17(2):219-26. PubMed ID: 4549571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis: correlation of delayed hypersensitivity, MLC reactivity and lymphocytotoxicity with disease activity.
    Broom BC; MacLaurin BP
    Clin Exp Immunol; 1973 Nov; 15(3):355-64. PubMed ID: 4271772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity during follow-up of patients with sarcoidosis of varying duration.
    Selroos O; Nikinmaa B; Koivunen E; Riska H; Tiitinen H; Weber T
    Clin Exp Immunol; 1982 Oct; 50(1):25-33. PubMed ID: 7172509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell mediated immunity in sarcoidosis patients].
    Haskovcová H; Hausner P; Altmann V; Votava V
    Allerg Immunol (Leipz); 1976; 22(2):123-6. PubMed ID: 136877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular immunity and cell composition of bronchoalveolar lavage fluid in patients with sarcoidosis].
    Solodkovskiĭ ML
    Probl Tuberk; 1987; (12):58-60. PubMed ID: 3444829
    [No Abstract]   [Full Text] [Related]  

  • 10. [T-lymphocyte subpopulations in sarcoidosis].
    Gergert VIa; Miuller Sh; Kolodiazhnaia NS
    Probl Tuberk; 1984 Sep; (9):65-9. PubMed ID: 6334302
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro lymphocyte immunoreactivity in sarcoidosis patients. Stimulation with Kveim antigens].
    Tartaglino B; Albera C; Vietti Ramus G; Cesano L
    Arch Sci Med (Torino); 1982; 139(2):183-6. PubMed ID: 7138284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between T-rosette-forming cells and cellular immunity in sarcoidosis.
    Topilsky M; Shohat B; Spitzer S; Joshua H
    Ann N Y Acad Sci; 1976; 278():108-15. PubMed ID: 9022
    [No Abstract]   [Full Text] [Related]  

  • 13. [Subpopulation composition and cytochemical activity of the blood T-lymphocytes in respiratory sarcoidosis patients].
    Abramovskaia AK; Shpakovskaia NS
    Probl Tuberk; 1987; (10):57-60. PubMed ID: 3501115
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible afferent limb immune defect in sarcoid lymphocytes.
    Ogunye O; Young R
    East Afr Med J; 1982 Mar; 59(3):199-205. PubMed ID: 6982809
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular components of the bronchoalveolar lavage correlate with lung function impairment and extrapulmonary involvement markers in active sarcoidosis.
    Chorostowska-Wynimko J; Leśniewska-Radomska D; Krychniak-Soszka A; Remiszewski P; Szopiński J; Wesołowski S; Kuś J; Skopińska-Rózewska E
    J Physiol Pharmacol; 2004 Sep; 55 Suppl 3():41-7. PubMed ID: 15611592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumors and sarcoidosis: considerations apropos of a 4-year follow-up of 39 cases of sarcoidosis].
    Vallina Alvarez E; Arribas Castrillo JM; Velasco Alvarez A; Quiroga Prado L; Cartón Sánchez JA; Díaz Sánchez J
    Rev Clin Esp; 1986 Jan; 178(1):13-5. PubMed ID: 3961229
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with evaluation of cell-mediated immunity by Imunoskintest Sevac.
    Kolek V; Bacovský J; Krcová I; Cechácek M; Vepreková A
    Acta Univ Palacki Olomuc Fac Med; 1987; 116():299-306. PubMed ID: 2962441
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cell-mediated immunity in patients with atopic allergic diseases].
    Kosturkov G; Bozhkov B; Savov S; Dimitrov V
    Vutr Boles; 1986; 25(4):60-6. PubMed ID: 3490058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new feasibility of immune stimulation in diseases with reduced cell immunity? (author's transl)].
    Pavelka K; Müller W
    Cas Lek Cesk; 1981 May; 120(19):566-70. PubMed ID: 7237501
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of inhalative exposure to dioxins in wood preservatives on cell-mediated immunity in day-care center teachers.
    Wolf N; Karmaus W
    Environ Res; 1995 Feb; 68(2):96-105. PubMed ID: 7601078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.